Jing Xiao is a Vice President of Sky9 Capital. She focuses on investing in biotech, medical services, and healthcare.
Jing has over 3 years of healthcare investment experience plus startup experience at a digital healthcare company. Companies she invested in include Trifo and Joint Therapeutics. Previously, she worked at TusStar and Yidu Cloud.
Jing received her Ph.D. from the School of Medicine of Tsinghua University and her B.S. from the School of Life Sciences of Tsinghua University.